Zolantidine

Zolantidine
Systematic (IUPAC) name
N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-1,3-benzothiazol-2-amine
Identifiers
CAS Number 104076-38-2
ATC code None
PubChem CID 91769
ChemSpider 82866
ChEMBL CHEMBL419296
Chemical data
Formula C22H27N3OS
Molar mass 381.5 g/mol

Zolantidine is a brain-penetrating selective histamine H2 receptor (HRH2) antagonist developed by Smith, Kline & French, with the research code of SK&F 95282. It is a benzthiazole derivative with a 30-fold higher potency for H2 receptors than other peripheral and central receptors.[1]

References

  1. Calcutt, CR; Ganellin, CR; Griffiths, R; Leigh, BK; Maguire, JP; Mitchell, RC; Mylek, ME; Parsons, ME; Smith, IR; Young, RC (January 1988). "Zolantidine (SK&F 95282) is a Potent Selective Brain-penetrating Histamine H2-receptor Antagonist". British Journal of Pharmacology 93 (1): 69–78. PMID 2894879.
This article is issued from Wikipedia - version of the Friday, January 08, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.